• Skip to primary navigation
  • Skip to content
  • Skip to footer
CardioCell

CardioCell

Breakthrough Cardiovascular Technology

  • About Us
    • Overview
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Our Stem Cells
    • Manufacturing
    • Quality Control
    • Exclusive License
  • Clinical Trials
    • Overview
    • Chronic Heart Failure
    • Heart Failure in Patients With Left Ventricular Assist Devices
    • Acute Myocardial Infarction
  • News
    • Press Releases
    • Media Coverage
    • Publications
  • Events
  • LinkedIn

News

May 27, 2014

Indonesia’s BPOM Grants IND Approval for SCI to Conduct a Phase II Clinical Trial Using Stemedica’s Mesenchymal Stem Cells to Treat Acute Myocardial Infarction

News May 27, 2014 Indonesia’s BPOM Grants IND Approval for SCI to Conduct a Phase II Clinical Trial Using Stemedica’s Mesenchymal Stem Cells to Treat Acute Myocardial Infarction SAN DIEGO — May 27, 2014 — Stemedica Cell Technologies Inc., a leading manufacturer of adult, allogeneic

Read More

News,  Press Releases

  • « Previous Page
  • Page 1
  • …
  • Page 5
  • Page 6
  • Page 7

Footer

About Us

  • Overview
  • Board of Directors
  • Scientific Advisory Board

Technology

  • Our Stem Cells
  • Manufacturing
  • Quality Control
  • Exclusive License

Clinical Trials

  • Overview
  • Chronic Heart Failure
  • Heart Failure in Patients With Left Ventricular Assist Devices
  • Acute Myocardial Infarction
<section id="bpfwp_contact_card_widget-1" class="widget widget_bpfwp_contact_card_widget"><div class="widget-wrap"><h3 class="widgettitle widget-title">Contact</h3>
info@stemcardiocell.com
</div></section>

Copyright © 2023 · Business Pro Theme on Genesis Framework · WordPress · Log in